首页> 外文期刊>American Journal of Translational Research >Efficacy of montmorillonite and vitamin AD combined with zinc preparation in children with diarrheal disease and its effect on inflammatory factors
【24h】

Efficacy of montmorillonite and vitamin AD combined with zinc preparation in children with diarrheal disease and its effect on inflammatory factors

机译:蒙脱石和维生素Ad结合腹泻疾病儿童锌制剂的疗效及其对炎症因素的影响

获取原文
           

摘要

Objective: To investigate the effect of montmorillonite and vitamin AD combined with zinc preparation in children with diarrheal disease and its effect on inflammatory factors. Methods: A total of 156 children with diarrheal diseases admitted to our hospital from January 2018 to January 2020 were enrolled and divided into two groups (n=78 for each) using random number table. The control group (CG) was treated with montmorillonite, and the observation group (OG) was additionally treated with vitamin AD and zinc. Both groups completed 7 d of treatment and 3 months of follow-up to compare the efficacy rate, time to onset of symptom relief, inflammatory factor levels, T-lymphocyte levels, adverse drug reactions, and relapse rate. Results: The efficacy rate of 7 d treatment in the OG was 94.87%, higher than that of 56.41% in the CG ( P 0.05). After intervention, the OG had normal frequency of defecation, shorter time for stool to return to normal appearance, shorter duration of antiemetic, antipyretic, antidiarrheal treatment and shorter hospital stay than those of the CG ( P 0.05). The OG exhibited lower levels of CRP, TNF-α, NO, and PCT and higher levels of SOD than the CG ( P 0.05). The OG had lower levels CD3 + and CD4 + at 7 d after treatment, lower CD8 + levels and higher CD4 + /CD8 + levels than the CG ( P 0.05). The relapse rate at 6 months after treatment in the OG was lower than that in the CG ( P 0.05). Conclusion: The combination of montmorillonite, vitamin AD and zinc preparation can achieve higher short-time efficacy, shorten the time of disappearance of symptoms, reduce the level of inflammatory factors, and improve the level of T-lymphocytes, without increasing the incidence of adverse drug reactions.
机译:目的:探讨蒙脱石及维生素Ad结合腹泻疾病儿童锌制备的影响及其对炎症因素的影响。方法:从2018年1月到2018年1月至2020年,共参加了156例腹泻疾病的儿童,使用随机数表注册并分为两组(每个人为每次)。对照组(CG)用蒙脱石处理,并用维生素AD和锌另外处理观察组(OG)。两组均完成了7天的治疗和3个月的后续比较,比较疗效率,症状缓解的时间,炎症因子水平,T淋巴细胞水平,不良药物反应和复发率。结果:og中7 d处理的疗效率为94.87%,高于CG的56.41%(P <0.05)。干预后,OG具有正常的排便频率,粪便恢复到正常外观的时间较短,止血剂持续时间较短,止吐剂,反气管治疗和较短的医院停留而不是CG(P <0.05)。 OG表现出较低水平的CRP,TNF-α,NO和PCT和高水平的SOD比CG(P <0.05)。在处理后,og含有较低的CD3 +和CD4 +,下降,降低CD8 +水平和高于CG的CD4 + / CD8 +水平(P <0.05)。在OG处理后6个月的复发率低于CG(P <0.05)。结论:蒙脱石,维生素AD和锌制剂的组合可实现较高的短时间疗效,缩短症状消失的时间,降低炎症因素的水平,提高T淋巴细胞水平,而不增加不良的发病率药物反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号